Neuronetics, Inc. (STIM) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Neuronetics, Inc. (STIM) Bundle
Designed for accuracy, our (STIM) DCF Calculator enables you to evaluate Neuronetics, Inc. valuation using real-world financial data and offers complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 62.7 | 49.2 | 55.3 | 65.2 | 71.3 | 74.6 | 78.0 | 81.6 | 85.3 | 89.2 |
Revenue Growth, % | 0 | -21.41 | 12.32 | 17.89 | 9.42 | 4.56 | 4.56 | 4.56 | 4.56 | 4.56 |
EBITDA | -26.9 | -21.1 | -26.6 | -31.3 | -22.8 | -31.9 | -33.3 | -34.8 | -36.4 | -38.1 |
EBITDA, % | -42.98 | -42.78 | -48.01 | -47.94 | -31.9 | -42.72 | -42.72 | -42.72 | -42.72 | -42.72 |
Depreciation | 1.1 | .9 | 1.1 | 1.6 | 2.0 | 1.6 | 1.7 | 1.8 | 1.9 | 1.9 |
Depreciation, % | 1.7 | 1.91 | 1.92 | 2.53 | 2.81 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 |
EBIT | -28.0 | -22.0 | -27.6 | -32.9 | -24.8 | -33.5 | -35.0 | -36.6 | -38.3 | -40.0 |
EBIT, % | -44.68 | -44.69 | -49.92 | -50.47 | -34.71 | -44.89 | -44.89 | -44.89 | -44.89 | -44.89 |
Total Cash | 76.6 | 50.8 | 96.3 | 71.9 | 60.6 | 72.3 | 75.6 | 79.1 | 82.7 | 86.5 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 6.6 | 7.2 | 7.8 | 13.8 | 17.8 | 12.7 | 13.3 | 13.9 | 14.5 | 15.2 |
Account Receivables, % | 10.48 | 14.55 | 14.07 | 21.2 | 25 | 17.06 | 17.06 | 17.06 | 17.06 | 17.06 |
Inventories | 2.8 | 3.7 | 6.6 | 8.9 | 8.1 | 7.3 | 7.6 | 8.0 | 8.3 | 8.7 |
Inventories, % | 4.43 | 7.55 | 11.87 | 13.65 | 11.34 | 9.77 | 9.77 | 9.77 | 9.77 | 9.77 |
Accounts Payable | 4.6 | 3.7 | 4.3 | 2.4 | 4.8 | 4.9 | 5.2 | 5.4 | 5.7 | 5.9 |
Accounts Payable, % | 7.38 | 7.61 | 7.77 | 3.73 | 6.66 | 6.63 | 6.63 | 6.63 | 6.63 | 6.63 |
Capital Expenditure | -.8 | -.7 | -2.4 | -3.3 | -2.4 | -2.3 | -2.4 | -2.5 | -2.6 | -2.7 |
Capital Expenditure, % | -1.3 | -1.48 | -4.25 | -5.01 | -3.32 | -3.07 | -3.07 | -3.07 | -3.07 | -3.07 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -33.1 | -25.9 | -31.5 | -34.7 | -24.8 | -33.5 | -35.0 | -36.6 | -38.3 | -40.0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -37.5 | -28.1 | -35.7 | -46.6 | -26.0 | -28.0 | -36.4 | -38.1 | -39.8 | -41.6 |
WACC, % | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 |
PV UFCF | ||||||||||
SUM PV UFCF | -132.8 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -42 | |||||||||
Terminal Value | -461 | |||||||||
Present Terminal Value | -271 | |||||||||
Enterprise Value | -404 | |||||||||
Net Debt | 3 | |||||||||
Equity Value | -407 | |||||||||
Diluted Shares Outstanding, MM | 29 | |||||||||
Equity Value Per Share | -14.20 |
What You Will Get
- Real STIM Financial Data: Pre-filled with Neuronetics’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Neuronetics’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- 🔍 Real-Life STIM Financials: Pre-filled historical and projected data for Neuronetics, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Neuronetics’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Neuronetics’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Neuronetics, Inc. (STIM).
- Step 2: Review Neuronetics' pre-filled financial data and forecasts.
- Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose Neuronetics, Inc. (STIM)?
- Save Time: Quickly access comprehensive data without the need for extensive research.
- Enhance Accuracy: Utilize validated financial metrics to ensure precise evaluations.
- Fully Customizable: Adjust parameters to align with your specific investment strategies and forecasts.
- Easy to Interpret: Intuitive visualizations and summaries simplify complex information for better decision-making.
- Trusted by Professionals: Developed for investors who demand high-quality insights and functionality.
Who Should Use Neuronetics, Inc. (STIM)?
- Healthcare Professionals: Understand the latest advancements in neuromodulation therapies and their applications.
- Researchers: Integrate cutting-edge technologies into studies focused on mental health treatments.
- Investors: Evaluate market trends and potential returns associated with Neuronetics, Inc. (STIM) stock.
- Clinical Analysts: Enhance your analysis with customizable models specific to neurostimulation devices.
- Entrepreneurs: Discover how innovative companies like Neuronetics, Inc. (STIM) are reshaping the mental health landscape.
What the Template Contains
- Pre-Filled DCF Model: Neuronetics, Inc.’s (STIM) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Neuronetics, Inc.’s (STIM) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.